Browse the evidence

Obese individuals exhibit significantly lower plasma CML levels compared to lean individuals, a phenomenon attributed to the trapping of CML in adipose tissue via RAGE.

Standard blood tests for CML (a marker of glycation/oxidative stress) may underestimate the total body burden of these compounds in obese individuals because the compounds are trapped in fat tissue. This trapping mechanism contributes to local inflammation and insulin resistance. Weight loss (bariatric surgery) was shown to increase plasma CML, suggesting that reducing fat mass releases this trapped burden back into circulation.

Gut microbiota dysbiosis and subsequent bacterial translocation of lipopolysaccharides (LPS) into systemic circulation cause metabolic endotoxemia, which triggers chronic low-grade inflammation and insulin resistance.

If you have obesity or type 2 diabetes, your gut bacteria may be leaking inflammatory substances (LPS) into your bloodstream, causing insulin resistance. Focus on improving gut health through diet (e.g., fiber, prebiotics) to reduce this 'leaky gut' effect and lower systemic inflammation.

In normogonadal men, low plasma levels of free testosterone and SHBG do not independently predict insulin resistance, beta-cell dysfunction, or hepatic glucose output; their association with metabolic risk is mediated entirely by adiposity.

For men with normal testosterone levels, low T is not the independent cause of insulin resistance. The observed link between low T and metabolic risk is driven by obesity, particularly truncal fat. Focusing on reducing abdominal adiposity is more effective for improving insulin sensitivity than attempting to raise testosterone levels through therapy, provided baseline levels are normal.

In normogonadal men, lower plasma bioavailable testosterone levels are predictive of greater fat deposition in subcutaneous truncal and peripheral adipose tissues.

In men with normal testosterone, lower levels within the normal range are associated with higher subcutaneous fat, especially around the trunk. This suggests that maintaining healthy testosterone levels may help manage body fat distribution, although it is not the sole determinant of insulin resistance.

DNA methylation levels in blood are significantly associated with specific blood serum metabolic traits (metabotypes), independent of underlying genetic variants, suggesting epigenetic regulation of human metabolism.

This research highlights that your metabolic health is not just written in your DNA sequence but is also regulated by epigenetic marks (DNA methylation) influenced by your lifestyle and environment. While this study doesn't prescribe a specific diet or exercise, it underscores the importance of lifestyle factors (like smoking cessation, noted as a driver for some associations) in maintaining healthy metabolic profiles through epigenetic regulation.

Shorter leukocyte telomere length (LTL) is associated with a significantly higher risk of all-cause mortality and cardiovascular disease (CVD).

Your blood test's telomere length isn't a destiny, but a status report. Shorter telomeres correlate with higher heart disease and mortality risk. You can influence this trajectory by managing stress, exercising regularly, maintaining a healthy weight, and avoiding smoking, as these factors are linked to slower telomere shortening.

Metabolic syndrome prevalence in Indian adults is 30%, with significantly higher rates in females (35%) compared to males (26%), and in urban residents (32%) compared to rural (22%) and tribal (28%) populations.

If you are an adult in India, your risk of metabolic syndrome is about 1 in 3. Women and city dwellers face a higher risk. Regular screening for blood pressure, blood sugar, and cholesterol is crucial, especially if you live in an urban area or are female.

Higher surgical volume (>=15 procedures per 2 months) significantly increases the likelihood of success and reduces specific complications after laparoscopic adjustable gastric banding.

If you are getting a gastric band, choose a high-volume center (>=15 procedures per 2 months). The study shows that patients at these centers have almost twice the chance of success and lower complication rates compared to those at low-volume centers.

Spexin gene expression and circulating levels are significantly down-regulated in obese human adipose tissue and serum compared to non-obese individuals.

In obese humans, the body produces significantly less of the peptide Spexin in fat tissue and blood compared to lean people. This deficiency is correlated with higher levels of Leptin and increased fat uptake, suggesting that Spexin plays a role in preventing obesity.

The physical activity improvements from a 50-day social networking intervention are not statistically maintained 3 months after the intervention ends.

Be aware that the benefits of a 50-day fitness challenge may fade after you stop. To keep the gains, you likely need to continue some form of tracking, social accountability, or structured activity beyond the initial 50 days.

The human energy homeostatic system is evolutionarily biased towards weight gain and fat storage, making long-term weight loss difficult to achieve through diet and exercise alone.

Understand that your body is designed to regain lost weight. This is not a moral failing but a biological reality driven by hormones like leptin and neuropeptide Y. Long-term success often requires addressing these hormonal drivers, potentially through medical interventions, rather than relying solely on willpower.

Leptin resistance in common obesity prevents the hormone from signaling satiety to the brain, rendering high circulating levels ineffective for weight loss.

In common obesity, your body produces plenty of leptin, but your brain doesn't hear it. This 'leptin resistance' is a key barrier. Treatments that simply add leptin have largely failed; effective strategies must overcome this resistance.

Neuropeptide Y (NPY) and Agouti-Related Protein (AGRP) are potent orexigenic peptides that increase food intake and decrease energy expenditure, particularly when leptin signaling is low.

When you are in a caloric deficit, your body increases NPY and AGRP to make you hungry and slow your metabolism. This is a normal survival mechanism.

Alpha-melanocyte-stimulating hormone (α-MSH) and Cocaine- and Amphetamine-Regulated Transcript (CART) reduce food intake and increase energy expenditure, acting as counter-regulatory peptides to NPY and AGRP.

α-MSH and CART help you feel full and burn energy. In obesity, these signals are often suppressed.

High-fat diet exposure causes reduced hypothalamic mTORC1 signaling, which contributes to leptin resistance and diet-induced obesity.

This research suggests that chronic high-fat intake disrupts a specific brain signaling pathway (mTORC1) that tells your brain you are full. This disruption leads to resistance to the hormone leptin, making it harder to regulate appetite. While this is a rodent study, it implies that dietary composition (specifically fat content) directly impacts brain signaling mechanisms that control hunger and weight.

CNTF analog CNTFAx15 can induce anorexia and activate mTORC1 signaling even in states of leptin resistance caused by high-fat diets.

This study shows that a specific cytokine analog (CNTFAx15) can reduce food intake in obese animals even when they are resistant to the natural hormone leptin. This suggests that targeting specific brain pathways (like mTORC1) might be a viable strategy for treating obesity where standard hormonal signals fail.

Historical weight-loss drugs (Thyroid hormones, DNP, Amphetamines) failed due to narrow therapeutic windows and severe adverse effects, despite some efficacy.

Historical weight-loss drugs like DNP, thyroid extracts, and amphetamines were largely withdrawn or restricted due to severe side effects (cataracts, heart issues, addiction) and limited efficacy (<10% weight loss). Their failure highlights the need for safer, more effective modern therapies like polyagonists.

In young military recruits undergoing high-intensity training, daily food intake does not acutely regulate or compensate for daily energy expenditure, as there is no significant day-to-day correlation between the two.

Do not rely on your daily hunger to tell you how much to eat based on your daily activity. In high-activity environments like military training, people do not automatically eat more on heavy training days. To maintain energy balance, you must consciously manage your food intake regardless of day-to-day exercise variations.

Non-nutritive sweeteners are less acidogenic than sugar and may increase oral pH, potentially reducing the risk of dental caries.

If you are concerned about tooth decay, switching from sugar-sweetened drinks to those with non-nutritive sweeteners is a beneficial change. The research indicates that NNSs produce less acid in the mouth than sugar, leading to a higher oral pH which is protective against cavities.

Flavin Monooxygenase 3 (FMO3) activity promotes dyslipidemia and atherosclerosis by regulating hepatic lipogenesis, gluconeogenesis, and impairing transintestinal cholesterol export (TICE).

FMO3 is an enzyme that not only processes nutrients into TMAO but also directly regulates how your liver handles fats and sugars. High FMO3 activity is linked to worse lipid profiles and increased atherosclerosis risk. This regulation happens through complex gene signaling (FXR, LXR, PPARa) that controls cholesterol export and fat storage.

Indian diets exhibit a significant caloric deficit in protein sources (6-8% of total calories) compared to the EAT-Lancet reference diet (29%), driven by low consumption of legumes, animal proteins, and tree nuts across all income and geographic groups.

Current Indian dietary patterns, even among the wealthy, fail to provide adequate protein, contributing to health issues. To align with healthy standards, individuals must significantly increase intake of protein-rich foods like legumes, nuts, dairy, and potentially animal proteins, while reducing the disproportionate share of calories derived from cereals.

Lower morning urinary cortisol levels are associated with greater difficulty getting to sleep (sleep onset latency) during the menopausal transition, challenging the assumption that high stress/cortisol always correlates with worse sleep onset.

If you have trouble falling asleep, don't just assume it's 'high stress.' This research suggests that lower cortisol levels might actually be linked to sleep onset issues in some women. Focus on calming cognitive arousal and managing hot flashes rather than just trying to lower stress hormones.

Low serum levels of IGF-I are associated with the severity of NAFLD, including inflammation, hepatocyte ballooning, and fibrosis, even in non-GHD patients.

If you have NAFLD, your IGF-I levels might be low, which correlates with more severe liver damage. While this doesn't mean you should take IGF-I supplements (which are not standard), it highlights the importance of the GH-IGF-I axis in liver health.

Chronic insomnia is associated with a 24-hour hypersecretion of ACTH and cortisol (HPA axis activation) that retains a normal circadian rhythm, indicating a disorder of central nervous system hyperarousal rather than simple sleep loss.

Chronic insomnia is not just about not sleeping; it is a state of constant physiological stress (high cortisol/ACTH) that persists day and night. Treatment should focus on reducing this overall physiological and emotional hyperarousal, not just on improving sleep duration or using standard hypnotics. Consider therapies that target stress system down-regulation.